Journal of Andrology, Vol. 24, No. 1, January/February 2003
Copyright © American Society of Andrology
Lack of RBM Expression as a Marker for Carcinoma In Situ of Prepubertal Dysgenetic Testis
LETIZIA SCHREIBER*,
BEATRIZ LIFSCHITZ-MERCER*,
GEDALIA PAZ
,
HAIM YAVETZ
,
ZVI ZADIK
,
KRZYSZTOF KULA
,
JOLANTA SLOWIKOWSKA-HILCZER
,
RODOLFO REY||,
DAVID J. ELLIOTT¶ AND
BATIA BAR-SHIRA MAYMON
From the * Institute for the Study of Pathology
and the
Institute of the Study of Fertility,
Lis Maternity Hospital, Tel-Aviv Sourasky Medical Center, Sackler Faculty of
Medicine, Tel-Aviv University, Tel-Aviv, Israel;
Pediatric Endocrine Unit, Kaplan Medical
Center, Rehovot, Israel;
Department of Andrology
and Reproductive Endocrinology, Institute of Endocrinology, Medical University
of Lodz, Lodz, Poland; || Endocrine Research Center,
R. Gutierrez Children's Hospital, Buenos Aires, Argentina; and¶
Institute for Human Genetics, The International
Center for Life, University of Newcastle upon Tyne, Newcastle upon Tyne,
United Kingdom.
| Correspondence to: Batia Bar-Shira Maymon, DSc, Institute of the Study of
Fertility, Lis Maternity Hospital, Tel-Aviv Sourasky Medical Center, 6 Weizman
Street, Tel-Aviv 64239, Israel. |
Individuals with various intersex states who carry Y-chromosome material
bear a high risk of developing testicular neoplasia. In order to gain more
insight into the pathogenesis of this neoplasia, the current study evaluates
the differentiation of the seminiferous epithelium in 46,XY dysgenetic male
pseudohermaphroditism. Immunohistochemical evaluation was performed using the
germ cell-specific RNA-binding motif (RBM) protein (encoded by the
Y-chromosome) to identify normal germ cells, whereas placental alkaline
phosphatase (PLAP) was used to detect neoplastic germ cells. Differentiation
of somatic Sertoli cells was assessed using cytokeratin-18 (CK-18) and
anti-Müllerian hormone (AMH) as markers for immature Sertoli cells.
Specimens were taken from surgically removed dysgenetic gonads of five
children (46XY karyotype). Intratubular germ cell neoplasia (carcinoma in situ
[CIS] of the testis) was detected in all of them. Normal germ cells revealed
immunoreactivity for RBM, whereas the PLAP-positive neoplastic germ cells were
negative for RBM expression. Sertoli cells revealed an immature phenotype
indicated by AMH expression in their cytoplasm. The design of the current
study is unique in its assessment of the state of germ cell differentiation in
dysgenetic gonads by the use of the RBM protein, which was expressed only in
normal germ cells but not in those of CIS. Testicular dysgenesis interrupted
the normal differentiation of the germ line and had no effect on the immature
phenotype of the prepubertal Sertoli cells. This points toward the germinal
component of CIS as the precursor for the promotion of testis cancer.
Key words: male pseudohermaphroditism, testicular carcinoma in situ, germ cell differentiation, Sertoli cell differentiation, immunohistochemistry
This article has been cited by other articles:

|
 |

|
 |
 
L. Frydelund-Larsen, P. H. Vogt, H. Leffers, A. Schadwinkel, G. Daugaard, N. E. Skakkebaek, and E. Rajpert-De Meyts
No AZF deletion in 160 patients with testicular germ cell neoplasia
Mol. Hum. Reprod.,
September 1, 2003;
9(9):
517 - 521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Slowikowska-Hilczer, T. E. Romer, and K. Kula
Neoplastic Potential of Germ Cells in Relation to Disturbances of Gonadal Organogenesis and Changes in Karyotype
J Androl,
March 1, 2003;
24(2):
270 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by The American Society of Andrology.